No one likes to think about childhood cancer. But for many families, the reality is a stark one. Cancer is the number one cause of non-=violent deaths for children in the United States. However, just four percent of federal funding for cancer research is allocated toward pediatric cancer. It is why visionary individuals and organizations must bridge the gap.
Families across the Southwest seek treatment at Phoenix Children’s Center for Cancer and Blood Disorders (CCBD). Here, children battling cancer receive cutting edge care with a compassionate touch. Still, a cure for pediatric cancers is within reach. An unwavering commitment to research promises to get us closer. Investment in leadership, infrastructure and resources will enable understanding that leads to breakthrough discoveries.
As the largest program of its kind in Arizona for children, the Center embraces robust translational pediatric research, including cellular therapy and other emerging treatments. There are currently more than 175 clinical trials offered through the CCBD for patients with leukemia, lymphoma, solid tumors, brain tumors and other rare cancers. Clinical trials offer children and families access to the newest cutting edge treatments available and help researchers refine exacting dosages and efficacy.